Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

24 trials with published results (12%)

Research Maturity

117 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.3%

15 terminated out of 206 trials

Success Rate

88.6%

+2.1% vs benchmark

Late-Stage Pipeline

24%

50 trials in Phase 3/4

Results Transparency

21%

24 of 117 completed with results

Key Signals

24 with results89% success15 terminated

Data Visualizations

Phase Distribution

167Total
Not Applicable (71)
Early P 1 (2)
P 1 (20)
P 2 (24)
P 3 (24)
P 4 (26)

Trial Status

Completed117
Unknown33
Recruiting20
Terminated15
Withdrawn8
Not Yet Recruiting7

Trial Success Rate

88.6%

Benchmark: 86.5%

Based on 117 completed trials

Clinical Trials (206)

Showing 20 of 20 trials
NCT07690202RecruitingPrimary

Living With Chronic Kidney Disease Without Renal Replacement Therapy: Experience of Women of Childbearing Age

NCT04190251Not ApplicableCompleted

PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program

NCT05565716Not ApplicableCompletedPrimary

Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension

NCT00304148Active Not RecruitingPrimary

SDCC - Prospective Cohort Study of Chronic Renal Insufficiency

NCT07380113Phase 4Not Yet Recruiting

Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP

NCT06047106Not ApplicableRecruitingPrimary

Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.

NCT03381950CompletedPrimary

Chronic Kidney Disease - Renal Epidemiology and Information Network

NCT07624305Phase 3Not Yet RecruitingPrimary

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

NCT04876963Completed

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT02947750Phase 2RecruitingPrimary

Neurovascular Transduction During Exercise in Chronic Kidney Disease

NCT07522944Not ApplicableRecruitingPrimary

AI-Guided Relaxation for Hemodialysis Anxiety

NCT06618859Not ApplicableRecruitingPrimary

Time-restricted Eating in Patients With Moderate Chronic Kidney Disease and Albuminuria

NCT07446296Not ApplicableRecruiting

Kidney Transplant Improvement Through New Exercise Training to Increase Capacity

NCT06561412Not ApplicableCompletedPrimary

Penn Produce Prescription and Chronic Kidney Disease Study

NCT05136664Phase 3Completed

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

NCT07426380Phase 1Recruiting

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

NCT07447375Not ApplicableRecruiting

Exercise During Hemodialysis: Impact on Sarcopenia and Sleep Quality

NCT07444203Recruiting

Transformative Research in Diabetic Nephropathy 2.0

NCT07421674Not Yet Recruiting

Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency

NCT03253172Not ApplicableActive Not RecruitingPrimary

Potassium Supplementation in CKD

Scroll to load more

Research Network

Activity Timeline